Sorrento Therapeutics Inc...

0.00
-0.00 (-100.00%)
At close: Mar 03, 2025, 3:53 PM
0.00
-57.14%
Pre-market: Jan 02, 2025, 09:30 AM EST

Sorrento Therapeutics Balance Sheet Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Cash & Equivalents 23.63M 36.66M 56.46M 22.52M 168.33M 20.43M 82.4M 39.04M 71.9M 31.67M 5.09M 3.47M 5.28M 3.43M 380.46K 21.88K n/a n/a n/a n/a
Short-Term Investments 26.34M 90.22M n/a n/a 297K 441K 1.11M 97.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments 17.18M 51.27M 256.4M 262.24M 309.99M 270.01M 189M 170.13M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 3.69M -73.25M -60.88M -10.43M 5.57M 3.25M 3.91M 590K 332K 148.06K 48.63K 22.73K 38.42K 22.73K n/a n/a n/a n/a n/a n/a
Receivables 24.47M 18.71M 15.51M 14.45M 4.36M 3.93M 2.98M 2.62M 732K 394.25K 79.76K 61.24K 246.04K n/a n/a n/a n/a n/a n/a n/a
Inventory 9.98M 8.11M 1.83M 3.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 11.95M 19.29M 12.43M 27.25M 6.58M 4.9M 3.17M 2M 1.28M 570.96K 80.92K 29.87K 29.81K 27.86K 14.06K n/a n/a n/a n/a n/a
Total Current Assets 96.37M 172.99M 86.23M 67.59M 179.56M 29.7M 89.65M 141.02M 73.92M 32.63M 5.25M 3.56M 5.55M 3.46M 394.52K 21.88K n/a n/a n/a n/a
Property-Plant & Equipment 138.44M 126.5M 73.91M 76.27M 24.38M 19.34M 12.71M 7.25M 2.28M 2.44M 1.48M 988.45K 95.93K 73.31K n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles 217.17M 339.23M 117.23M 101.61M 104.58M 109.31M 106.31M 24.54M 55.02M 57.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 376.47M 521.83M 449.59M 490.04M 495.16M 450.08M 311.93M 202.5M 67.63M 59.95M 1.53M 1.01M 134.35K 96.03K n/a n/a n/a n/a n/a n/a
Total Assets 472.84M 694.82M 535.82M 557.63M 674.73M 479.78M 401.59M 343.52M 141.54M 92.58M 6.78M 4.57M 5.69M 3.55M 394.52K 21.88K n/a n/a n/a n/a
Account Payables 47.52M 27.41M 24.71M 27.63M 13.82M 9.91M 8.28M 1.34M 1.66M 2.15M 439.53K 224.74K 181.8K 316.42K 2.33K 3.29K 471.79K 32.5K 84.3K 84.3K
Deferred Revenue 652K 1.11M 4.49M 3.64M 2.7M 3.86M 9.91M 110.9M 1.1M n/a n/a n/a 200K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 30.17M 55.06M 30.46M 42.91M 10.15M n/a 209K 4.83M 3.32M 373.93K n/a n/a n/a n/a n/a n/a n/a n/a 9.54K 9.54K
Other Current Liabilities 249.59M 55.87M 36.83M 41.03M 34.95M 65.18M 57.68M -86.2M 3.49M 2.95M 144.64K 134.6K 222.16K 36.65K n/a n/a n/a n/a 246.69K 245.93K
Total Current Liabilities 327.92M 139.45M 96.48M 115.21M 61.62M 78.95M 76.08M 30.87M 9.56M 5.48M 584.17K 359.34K 603.96K 353.07K 2.33K 3.29K 471.79K 32.5K 340.53K 339.77K
Long-Term Debt 104.34M 194.06M 142.56M 251.2M 223.14M 5.21M 47.11M 4.39M 8.83M 4.43M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 54.56M 161.81M 35.95M 35.04M 6.14M 6.01M 4.28M 7.07M 796K 1.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 166.59M 477.24M 298.61M 409.67M 405.6M 194.21M 239M 171.71M 23.27M 20.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities 494.51M 616.69M 395.09M 524.88M 467.23M 273.17M 315.08M 202.58M 32.83M 25.77M 584.17K 359.34K 603.96K 353.07K 2.33K 3.29K 471.79K 32.5K 340.53K 339.77K
Total Debt 134.5M 237.58M 169.39M 290.78M 233.29M 5.21M 47.32M 9.23M 12.15M 4.8M n/a n/a n/a n/a n/a n/a n/a n/a 9.54K 9.54K
Common Stock 52K 32K 28K 18K 13K 9K 6K 4K 4K 2.3K 30.01K 26.23K 25.08K 22.51K 1.11K 7.93K 14.21K 14.21K 14.21K 14.21K
Retained Earnings -1.96B -1.39B -958.28M -659.82M -367.75M -165.12M -174.25M -113.33M -67.52M -32.86M -10.95M -6.1M -2.87M -1.06M -1.66M -1.47M -1.2M -763.88K -1.07M -1.07M
Comprehensive Income 1.5M 1.03M 520K -270K 15K 242K -118K 73.58M -1.69M -932.61K -478.69K -185.39K n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity -18.61M 78.75M 165.15M 78.59M 209.47M 199.57M 80.04M 145.15M 108.71M 66.81M 6.2M 4.21M 5.08M 3.2M 392.19K 18.59K -471.79K -32.5K -340.53K -339.77K
Total Investments 43.52M 141.49M 256.4M 262.24M 310.29M 270.45M 190.11M 267.49M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a